You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Endocrine Tumor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA

Not yet recruiting
  • Adrenal Cortical Carcinoma
  • +3 more
  • individualized mRNA neoantigen vaccine (mRNA-0523-L001)
  • Shanghai, Shanghai, China
    Ruijin hospital, Shanghai Jiao-Tong University School of Medicin
Nov 19, 2023

Quality of Life and Tolerance of Patients Treated With

Not yet recruiting
  • Metastatic Neuroendocrine Tumour
    • Lyon, France
      Hospices Civils de Lyon, Hopital Lyon Sud
    Sep 12, 2023

    A Research Registry on Aggressive PitNETs

    Recruiting
    • Endocrine Tumor
      • Lyon, France
        Hospices Civils de Lyon - Groupement Hospitalier Est
      Aug 4, 2023

      Endocrine Tumor Trial in Vandœuvre-lès-Nancy

      Recruiting
      • Endocrine Tumor
        • Vandœuvre-lès-Nancy, France
          CHU Nancy
        Mar 8, 2022

        Gastro-enteropancreatic Neuroendocrine Tumor Trial (Pasireotide, Diazoxide)

        Withdrawn
        • Gastro-enteropancreatic Neuroendocrine Tumor
        • (no location specified)
        Feb 17, 2022

        Metastatic Cancer, Breast Cancer, Lobular Breast Carcinoma Trial in Madison (18F-fluorofuranylnorprogesterone, Liquid Biopsy,

        Recruiting
        • Metastatic Cancer
        • +2 more
        • Madison, Wisconsin
          UW Carbone Cancer Center
        Oct 10, 2023

        Lymph Node Metastases by NF-PanNENs

        Recruiting
        • Non Functioning Pancreatic Endocrine Tumor
          • Milan, Italy
            IRCCS San Raffaele Hospital
          Aug 23, 2022

          Asymptomatic Small Pancreatic Endocrine Neoplasms.

          Recruiting
          • Non Functioning Pancreatic Endocrine Tumor
          • Radiological imaging studies
          • Quality of Life Assessment
          • Milan, Italy
            IRCCS San Raffaele Hospital
          Mar 4, 2022

          Non-functional Neuroendocrine Tumors of Pancreatic Body and Tail

          Recruiting
          • Non Functioning Pancreatic Endocrine Tumor
          • Histopathological review, long-term prognosis and quality of life follow-up
          • Shanghai, Shanghai, China
            Department of Pancreatic Surgery, Fudan University Shanghai Canc
          Jun 8, 2023

          Tumor-Derived FGF19

          Recruiting
          • Colorectal Cancer
          • +2 more
            • Orlando, Florida
              Burnett School Biomedical Sciences
            Sep 28, 2023

            Advanced Carcinoid Tumor, Digestive System Neuroendocrine Tumor, Multiple Endocrine Neoplasia Type 1 Trial in Houston

            Recruiting
            • Advanced Carcinoid Tumor
            • +4 more
            • Houston, Texas
              M D Anderson Cancer Center
            Sep 22, 2022

            Metastatic Breast Cancer, Locally Advanced Breast Cancer, Hormone Receptor Positive Tumor Trial in Durham (Abemaciclib,

            Recruiting
            • Metastatic Breast Cancer
            • +2 more
            • Durham, North Carolina
              Duke University Medical Center
            Jun 7, 2022

            Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer, Metastatic Ovarian Cancer Trial run by the National Cancer Institute

            Recruiting
            • Metastatic Colorectal Cancer
            • +4 more
            • Young TIL
            • +4 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Jan 25, 2023

            Breast Cancer, Estrogen Receptor Positive Tumor, HER2-negative Breast Cancer Trial in Seoul (Ovarian function suppression with

            Not yet recruiting
            • Breast Cancer
            • +4 more
            • Ovarian function suppression with endocrine treatments
            • Seoul, Korea, Korea, Republic of
              Gangnam Severance Hospital
            Dec 18, 2022

            Multiple Endocrine Neoplasia Type 1, Pancreatic Neuroendocrine Tumor Trial in Nanning (EUS-guided fine-needle injection)

            Recruiting
            • Multiple Endocrine Neoplasia Type 1
            • Pancreatic Neuroendocrine Tumor
            • EUS-guided fine-needle injection
            • Nanning, Guangxi, China
              First Affiliated Hospital of Guangxi Medical University
            Sep 24, 2022

            Solid Tumor, Advanced Breast Cancer Trial in Milwaukee (Abemaciclib, Hydroxychloroquine 200 mg, Faslodex)

            Withdrawn
            • Solid Tumor
            • Advanced Breast Cancer
            • Milwaukee, Wisconsin
              Froedtert Hospital and the Medical College of Wisconsin
            Dec 21, 2022

            Neuroendocrine Tumor of Pancreas, Multiple Endocrine Neoplasia Type 1 Trial in Utrecht (High-dose-high precision MR-guided

            Recruiting
            • Neuroendocrine Tumor of Pancreas
            • Multiple Endocrine Neoplasia Type 1
            • High-dose-high precision MR-guided radiotherapy
            • Utrecht, Netherlands
              UMC Utrecht
            May 29, 2022

            PIK3CA Mutation, Solid Tumor, Adult, HER2-negative Breast Cancer Trial (RLY-5836, Fulvestrant, Palbociclib)

            Not yet recruiting
            • PIK3CA Mutation
            • +7 more
            • (no location specified)
            Mar 7, 2023

            Familial Investigations of Childhood Cancer Predisposition

            Recruiting
            • Acute Leukemia
            • +45 more
              • Memphis, Tennessee
                St. Jude Children's Research Hospital
              May 11, 2022

              Abemaciclib in Combination With Endocrine Therapy as First Line

              Recruiting
              • Breast Cancer/ Metastatic Breast Cancer
              • Munich, Germany
                Klinikum rechts der Isar der TU München, Klinik und Poliklinik f
              Apr 26, 2022

              Well Differentiated Pancreatic Endocrine Tumor Trial in Milano (Everolimus plus Octreotide LAR plus Metformin)

              Active, not recruiting
              • Well Differentiated Pancreatic Endocrine Tumor
              • Everolimus plus Octreotide LAR plus Metformin
              • Milano, Italy
                Fondazione IRCCS Istituto Tumori Milano
              Sep 3, 2021

              Neuroendocrine Tumors, Intestinal Well Differentiated Endocrine Tumor, Progressive Disease Trial in France (Lutathera)

              Recruiting
              • Neuroendocrine Tumors
              • +2 more
              • Angers, France
              • +21 more
              Aug 2, 2022

              Pituitary Tumours: Prevalence of Associated Neoplasia

              Recruiting
              • Pituitary Tumor
              • +4 more
              • Registration of familial forms and associated neoplasia
              • Pozzilli, IS, Italy
                Neuromed
              Aug 31, 2021

              Cancer, Young Adult, Pain Trial in Durham (Behavioral Symptom Management for Young Adult Cancer Survivors)

              Recruiting
              • Cancer
              • +9 more
              • Behavioral Symptom Management for Young Adult Cancer Survivors
              • Durham, North Carolina
                Duke Cancer Institute
              Aug 2, 2022

              Solid Tumor, Adult Trial (EOC202, albumin-bound paclitaxel)

              Not yet recruiting
              • Solid Tumor, Adult
              • EOC202
              • albumin-bound paclitaxel
              • (no location specified)
              Apr 7, 2022